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Summary
Rabies is an economically important zoonosis. This paper describes the extent of 
the economic impacts of the disease and some of the types of economic analyses 
used to understand those impacts, as well as the trade-offs between efforts to 
manage rabies and efforts to eliminate it. In many cases, the elimination of rabies 
proves more cost-effective over time than the continual administration of post-
exposure prophylaxis, animal testing and animal vaccination. Economic analyses 
are used to inform and drive policy decisions and focus political will, placing 
economics at the heart of rabies control.
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Introduction
Rabies is an economically unique zoonosis because most 
of its associated costs do not result from illness, but are 
the consequence of human deaths and efforts to prevent 
the disease in humans, livestock, wildlife and companion 
animals. This unique pattern of costs reflects two basic 
facts: the case fatality rate of rabies in humans is nearly 
100%, and the disease is completely preventable through 
timely post-exposure prophylaxis (PEP) with rabies vaccine 
(1). As a result, many individuals who are at very low risk of 
developing the disease still seek post-exposure vaccination, 
even though this may not be the recommendation of health 
professionals (2). 
Like all zoonotic diseases, rabies is maintained in an animal 
reservoir. Each rabies virus (RABV) variant has a unique 
geographical range and ecology, requiring different control 
and intervention strategies. In developed countries, where 
canine rabies has been eliminated, the virus may continue 
to circulate in wildlife, whereas in most developing 
countries, the principal reservoir is domestic dogs (Canis 
lupus familiaris). Human and livestock exposure is based 
on a multitude of risk factors (3, 4), and there are several 
pathways by which rabies causes economic damage. 
Although the close relationship between humans and dogs 
is the primary cause of RABV exposures for all variants, 
that relationship also provides many opportunities for 
mitigating its impact. 
Rabies exposures in humans, companion animals or 
livestock result in economic impacts associated with 
vaccination or death. Because rabies patients die quickly, and 
there is no effective therapy, the cost of illness is relatively 
small, especially in the developing world. In contrast, the 
direct costs arising from factors such as PEP and livestock 
deaths are substantial, and they have been characterised in 
numerous studies (3, 5, 6, 7). Rabies also has indirect costs, 
including vaccination of livestock and companion animals 
and testing of animals suspected of rabies (4, 8). Other 
impacts of rabies on the broader economy can be captured 
by examining changes in different sectors that result from 
the direct and indirect impacts of the disease (9).
Of all the variants, canine RABV has been studied the most 
extensively. The global economic impact of canine rabies 
has been estimated by several studies and results highlight 
the fact that Asia disproportionately bears the burden of 
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this zoonosis as a result of high levels of human deaths, 
high rates of PEP and low investment in preventative dog 
vaccination efforts. The total cost of canine rabies has been 
estimated to range from US$ 530 million in Latin America, 
Asia and Africa (10) to US$ 695 million in Asia and Africa 
(11). Hampson et al. (12) take into account the cost of 
human life lost by calculating disability-adjusted life years 
(DALYs) and estimate the overall global cost of canine rabies 
at US$ 8.6 billion. Anderson & Shwiff (13) account for 
the value of human life using a different methodology and 
arrive at an estimated global economic burden of canine 
rabies of US$ 124.2 billion annually. As a neglected disease, 
rabies disproportionately affects people in poor, rural areas, 
especially children (11, 14). These studies only consider 
costs incurred due to canine rabies and exclude costs arising 
from other RABV variants, implying that the real total cost 
of rabies presence worldwide is substantially higher.
Rabies is a preventable disease in that vaccination exists for 
humans, companion animals, livestock and wildlife, and a 
number of countries have succeeded in eliminating canine 
rabies, resulting in long-term cost savings (15, 16, 17). For 
example, canine rabies was eliminated from the United 
States of America (USA), through the coordinated efforts of 
state and federal agencies. One of the factors in the success 
of elimination efforts was the implementation of an oral 
rabies vaccination (ORV) programme in wild and domestic 
canids in Texas, the impact of which has been evaluated by 
Shwiff et al. (16). Economic analyses such as this help to 
capture the impact of rabies to society. They inform resource 
allocation and disease management decisions. Understanding 
the economic trade-offs between suppression and treatment 
of rabies in humans versus treatment in animals is crucial to 
focusing political will to address the impacts caused by the 
disease. The tools exist to eliminate the disease; however, the 
economics determine whether or not elimination is feasible. 
This reality emphasises the importance of understanding 
the benefits and costs associated with rabies management 
in all potential reservoirs. This paper will describe the types 
of economic analyses used in rabies research, and discuss 
the status of economic research regarding rabies, which 
includes human treatment, control efforts in wildlife and 
potential strategies for eliminating rabies.
Types of economic analyses
A variety of types of analyses is available to economists. 
Benefit–cost analyses (BCAs) or cost–benefit analyses 
(CBAs) are useful for measuring and comparing the 
economic efficiency of policy options. For example, 
Anderson et al. (8) conducted a BCA to compare two 
options for controlling vampire bat rabies in Mexico, 
and Elser et al. (18) conducted a retrospective BCA on a 
raccoon rabies elimination programme in New York State, 
USA. A general BCA decision framework for mitigation of 
disease spread at the wildlife–livestock interface has also 
been developed to identify, assemble, and measure the 
components vital to the biological and economic efficiencies 
of animal disease mitigation efforts (19). Cost-effectiveness 
analysis is used to measure an outcome per unit of effort 
(which does not have to be monetary). Wera et al. (20) used 
this technique to determine the cost-effectiveness of mass 
dog vaccination campaigns on Flores Island, Indonesia, 
defining cost-effectiveness as public cost per averted canine 
rabies case. These tools, and others, allow researchers to 
determine optimal rabies management choices and provide 
methodology to reveal the magnitude of the economic 
impact of rabies on society.
Common metrics to measure the impact of rabies include: 
the direct and indirect impacts from medical treatment 
for dog bites; direct and indirect treatment for PEP; dog 
vaccination efforts; livestock losses; and DALYs. Typical 
results provided by economic analyses of rabies impacts 
include the overall impact of the disease burden, cost per 
dog vaccinated, cost per human life saved, cost of PEP, 
cost of dog vaccination programmes, and DALYs. In most 
cases, costs associated with human PEP make up the largest 
component of costs. Unfortunately, most studies do not 
have sufficient data to make these studies replicable in other 
locations, which makes the results regionally specific.
A new class of models is being developed that strikes a 
balance between biological sophistication and the ability 
to identify optimal rabies management strategies while 
recognising management resource constraints. These 
models are individual-based stochastic simulations that 
explicitly account for the links between effort, cost, and 
biological outcomes. Additionally, the objectives of these 
models are to construct a framework that i) accounts for 
population and disease dynamics; ii) allows removal, 
permanent sterilisation, temporary contraception and 
vaccination; iii) allows strategies to vary temporally, 
spatially and demographically; iv) allows mixed strategies; 
v) accommodates various levels of data availability; and vi) 
is flexible enough to allow parameterisation and functional 
forms for a variety of wildlife species and diseases. In 
the future, these models may provide a way to more 
appropriately integrate biological realities and economic 
considerations to provide rabies managers with the power 
and flexibility to clearly highlight the benefits and costs of 
different elimination strategies.
Human rabies treatment
Human rabies treatment is expensive and comprises a 
significant portion of the overall economic impact of 
rabies. Treatment usually consists of a series of four to five 
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vaccinations over a span of several weeks, accompanied 
by a dose of rabies immunoglobulin (RIG). In the USA, 
medical costs for each suspected human rabies exposure, 
including PEP, are estimated to total US$ 3,000 (adjusted 
to 2017) and account for 70% of the cost of each rabies 
exposure event (5). In developing countries of Asia and 
Africa, PEP costs range from US$ 40 to US$ 64 (11, 21). 
However, many people seeking PEP are unable to receive 
the full course of treatment, so these costs reflect only 
partial treatment. Human or equine RIG is not available in 
many of these areas. In the Philippines and Tanzania, only 
about 1% of patients received RIG, while just 9% received 
RIG in South Africa (21). The cost of PEP is out of reach for 
many people in developing countries, where daily wages 
are often only US$ 1 or US$ 2 (22). 
Rabies by variant
In terms of economic analysis, canine rabies has been the 
most extensively studied RABV variant. This is likely the 
case for several reasons. Firstly, humans are at greater risk of 
contracting this variant because of their close relationship 
with dogs (C. lupus familiaris), giving rise to related impacts 
and generating interest in studying these impacts. Secondly, 
even if the variant of rabies is commonly found in wildlife, 
the route to human exposure is still mainly through dogs 
as they interact with wildlife, thereby potentially exposing 
humans. This section examines the literature of economic 
analyses for each variant. 
Raccoons
Raccoon (Procyon lotor) rabies is found primarily in the USA 
and Canada. It is enzootic in south-eastern Canada and in 
the north-eastern, mid-Atlantic and south-eastern regions 
of the USA (23, 24). Oral rabies vaccination has been used 
to prevent the spread of raccoon rabies westward, where 
abundant susceptible raccoon populations exist (25, 26). 
Between 2006 and 2010, approximately 38 million ORV 
baits were distributed along the Appalachian Ridge to form 
vaccination zones to strategically prevent the westward 
spread of raccoon rabies. These zones prevent the spread of 
the virus into other United States and Canadian territories, 
and so far, there has not been a breach of the ORV barrier 
(23, 27), indicating that this method of rabies management 
may be effective for the confinement and prevention of 
raccoon rabies and could be a component in potential 
strategies for eliminating the raccoon RABV variant (26). 
Assuming raccoon rabies would continue to move westward 
in the absence of these zones, the ORV programme, coupled 
with natural barriers (such as the Appalachian Mountains 
and various river systems), proves to be economically 
efficient. The cost of establishing and maintaining the 
ORV zones is estimated to be between US$ 58 million and 
US$ 148 million (27). The cost estimates of ORV in Ohio 
between 1997 and 2000 were US$ 102,261 per km2, and the 
mean baseline cost of blanket rabies prevention techniques 
for the state is estimated to be US$ 397,728 per year (28). 
Foroutan et al. (29) concluded that ground distribution of 
ORV costs less than air distribution, and the cost of the baits 
themselves accounts for 85% of total costs. 
Although there are very few human deaths attributable to 
the raccoon RABV variant in the USA, rabid raccoons pose 
a significant threat to humans and pets, due to the species 
being well adapted to life in urban and suburban areas (23). 
Humans are at risk of rabies through direct exposure, and 
exposure to pets that have been exposed to a rabid raccoon. 
Though there may not be a large number of human fatalities 
related to raccoon rabies, the presence of rabid raccoons 
does increase the number of livestock and pets annually 
tested for rabies, as well as the amount of PEP administered 
in that area (27).  
In March 2008, three cattle died in Hampshire County, 
West Virginia, after being exposed to a rabid raccoon. The 
remaining 85 cattle were euthanised once the dead cattle 
tested positive for rabies, in order to prevent the spread 
of the virus. In addition, ten people were evaluated for 
possible exposure to rabies following the event, and all ten 
received rabies PEP, resulting in an estimated total cost of 
US$ 103,985 for this single event (30). In a separate event 
in Guernsey, Ohio, another 64 calves were euthanised 
following a confirmed death from raccoon rabies in the 
herd, and six humans received PEP following the incident. 
The total cost of this event was US$ 44,974 (30). These cases 
highlight an important component of raccoon rabies: while 
direct contact with a rabid raccoon may occur, it is often the 
case that exposure is indirect through a raccoon interacting 
with dogs and cats (Felis catus) as well as livestock, resulting 
in potential human exposure.
Skunks and bats 
Skunk rabies cases comprise about 26% of all wild animal 
rabies cases in North America, and the three skunk RABV 
variants collectively have the broadest geographical 
distribution in the USA, occurring in 22 north and south-
central states and California (24). While there is no ORV bait 
available for skunks or bats, several baits are in development 
and research has highlighted the economic necessity for 
this development (31). In California specifically, rabies 
is enzootic, with striped skunks (Mephitis mephitis) and 
bats (Chiroptera) acting as the main wildlife reservoirs. 
Seventy percent of California rabies cases are linked to 
terrestrial species that most often include striped skunks, 
spotted skunks (Spilogale putorius), and grey foxes (Urocyon 
cinereoargenteus), and 30% of cases involve bats (31). 
684 Rev. Sci. Tech. Off. Int. Epiz., 37 (2)
Bats also comprise approximately 26% of all reported rabies 
cases in the USA, and are the second-most reported rabid 
animal (24). Since 2000, vampire bats (Desmodus rotundus) 
have been the leading cause of human rabies in Latin America 
and the Caribbean (32), and vampire bat rabies is a major 
public health concern in tropical and subtropical areas of 
Latin America (8). Vampire bats transmit RABV to livestock 
and humans through their haematophagous behaviour, and 
are often the species most responsible for the transmission 
of RABV to livestock (8). In cattle, bat rabies can result in 
hide damage, weight loss, decreased milk production and 
death. Rabies virus transmitted to humans by bats results in 
death if PEP is not administered (8). 
The vampire bat can be found in Mexico as far north as 
the states of Sonora and Tamaulipas, and could potentially 
extend into south Texas in the next few decades as a result 
of climate change (33). Between 1997 and 2006, the 
average annual number of PEP treatments administered in 
Mexico was 955, costing 1,500 Mexican pesos (US$ 77) per 
person (8). If vampire bat rabies were to spread to southern 
Texas, the total economic impact is estimated to be between 
US$ 7 million and US$ 9.2 million (33). Vaccination of bat 
populations through ORV and available vaccine strategies 
is not feasible (8). Primary means of vampire bat rabies 
mitigation are bat control and livestock vaccination. 
Livestock vaccination has been found to be economically 
efficient while bat control has not (8).
Dogs 
Rabies in canids causes the greatest economic impact of all 
the variants, in that 99% of all global human rabies cases 
are caused by domestic dogs (24). As a result, the canine 
variant has received the most research attention and most 
published evidence about the impact of rabies is about 
this variant. However, there is still a substantial lack of 
information regarding the overall economic impact of 
canine rabies and the value of dog vaccination programmes, 
as well as a lack of data that can be extrapolated to other 
canine rabies-endemic regions (25, 34). A few studies 
provide overall estimates of the global impact of canine 
rabies; however, the majority of the studies that address the 
economics of canine rabies deal with a specific region or 
dog vaccination programme evaluation and are unsuited for 
replication in other regions.
An estimated 7.5 million people receive PEP each year 
as a result of potential exposure to canine RABV, and the 
total cost of canine rabies has been estimated to range from 
US$ 530 million to US$ 124 billion, depending on the 
regions being considered and the cost components included 
(10, 11, 12, 13). The cost for an individual PEP treatment 
ranges between US$ 30 and US$ 40 across all regions (10), 
and it has been estimated that 83% of the total rabies control 
budget in both Asia and Africa is put towards PEP (35). 
Canine rabies causes an estimated 59,000 human deaths 
per year, although estimates can go as high as 69,000, and is 
responsible for the loss of 3.7 million DALYs annually (10, 
12). The majority of those deaths occur in Africa (36.4%) 
and Asia (59.6%), with only 0.05% of deaths occurring in 
the Americas, 70% of which occur in Haiti (12). India alone 
accounts for 35% of human deaths from canine rabies, but 
the estimated death rate was highest in the poorest countries 
in sub-Saharan Africa (12). The role of rabies prevention 
can be clearly seen when we look at the figures for PEP and 
dog vaccination in the different regions: for each human 
death attributed to canine rabies, Latin America performs 
41,000 PEP treatments and vaccinates 2.8 million dogs, 
Asia performs 200 PEP treatments and about 1,000 dog 
vaccinations, and Africa performs eight PEP treatments and 
vaccinates eight dogs (10). 
Several dog vaccination campaigns have been undertaken to 
address endemic canine rabies in developing countries. The 
World Health Organization (WHO), with funding support 
from the Bill and Melinda Gates Foundation, addressed 
canine rabies in three sites: South-eastern Tanzania; Cebu 
Province in the Philippines; and KwaZulu-Natal Province 
in South Africa (21). A study of the economic costs of 
these projects found that the cost per dog vaccinated 
varied (range: US$ 1.18 to US$ 6.61) and appeared to be 
influenced by human and dog density (costs were lower 
where densities were higher), as well as overall vaccination 
coverage. Transportation costs were insignificant in urban 
areas but they were an important cost driver in rural areas, 
where house-to-house campaigns were required to reach 
dispersed populations. The vaccine itself accounted for a 
very small portion of the total cost of dog vaccination. In 
contrast, the cost of the average human PEP course ranged 
from US$ 44.91 to US$ 64.38 across the three sites. It is 
important to note that many bite victims did not receive 
the full course of treatment, and very few received RIG 
(range: 1% to 9%). Others did not seek treatment at all, 
so the PEP costs reported here were lower than would be 
required if every bite victim received a complete course 
of PEP. This study demonstrated that the cost and success 
of a dog vaccination campaign will be highly site specific, 
varying according to the presence or absence of an existing 
rabies management programme, knowledge of the local dog 
population, and support from external donors. Léchenne 
et al. (36) reported that a mass dog vaccination campaign 
in N’Djamena, Chad, achieved more than 70% coverage 
and resulted in a 90% decrease in reported dog rabies 
cases within one year, illustrating the profound impact dog 
vaccination programmes can have on rabies prevalence.
Haiti remains one of the few rabies-endemic countries in 
the Western Hemisphere. It is estimated that only 31% 
of people exposed to rabies seek treatment, resulting in 
130 deaths each year (37). A survey conducted in Haiti 
revealed that 3.2% of respondents had experienced a dog 
bite in the previous year, which is problematic in a country 
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where the dog vaccination rate does not reach the 70% 
threshold recommended for herd immunity (38). Haiti 
represents a country where increased dog vaccination could 
significantly reduce the prevalence of rabies, but further 
knowledge of dog ecology and increased access to vaccines 
are necessary.
In 1987, a canine rabies outbreak took place in Hermosillo, 
Mexico, resulting in 2.5% of city residents being bitten by 
a dog, 60% of whom were administered PEP. The PEP cost 
of this single outbreak was an estimated US$ 682,500 per 
100,000 citizens (39). In 1988 in the USA, an epizootic 
of canine rabies began in South Texas. It continued for 
six years, during which time 216 domestic dogs and 
270 coyotes (Canis latrans) were confirmed rabid.  Over 
these six years, aerial baiting was used to dispense vaccine-
laden baits throughout the infected area, costing a total of 
over US$ 26 million (16). The integration of ORV was a 
major contributing factor that led to freeing the USA of 
canine rabies (26). Mass dog vaccination campaigns in 
Tanzania and Bali Island, Indonesia, have been successful 
in decreasing cases of rabies in dogs and humans (35). 
Flores Island, Indonesia, is populated by more than 
1.8 million humans and 236,500 dogs, and there have 
been 19 reported cases of human fatalities attributed to 
canine rabies (35). Between 2001 and 2011, the average 
annual cost of rabies and rabies control on Flores Island 
was approximately US$ 1.12 million. Costs associated 
with rabies and rabies control on Flores Island included 
the culling of dogs, PEP administration, mass vaccination, 
pre-exposure treatment, dog bite investigation, testing 
of dogs suspected of being rabid, and the quarantine of 
imported dogs (35). Of those costs, dog culling is the most 
expensive, accounting for 39% of the total cost, followed 
by PEP treatments (35%) and mass vaccination of canines 
(24%). The total cost of rabies control measures in humans 
on Flores Island is estimated to be US$ 4.82 million. In 
Indonesia, 150 to 300 fatal rabies cases in humans are 
reported annually (35).  
In most cultures, dogs provide companionship and 
are woven into the social fabric of everyday life, which 
provides the pathway to impacts but also the means by 
which elimination is possible. Vaccination of dogs is the 
key to prevention and elimination of RABV in dogs and 
humans, while PEP only prevents rabies in humans but 
does not have any potential to eliminate the disease (40). 
In addition, in developing countries, PEP is relatively 
expensive (costs may exceed two to three months of wages) 
and often difficult to obtain (3, 41, 42). Bögel and Meslin 
(40) determined that, after 15 years, a canine rabies control 
programme consisting of a combination of PEP and canine 
vaccination becomes more cost effective than PEP alone. 
In one African city, the costs of a combined programme of 
PEP and canine rabies vaccination achieved parity with the 
costs of PEP alone after six years (3). The economic analyses 
of canine rabies highlighted in this paper commonly point 
to several reoccurring themes, such as the fact that rabies 
is preventable and elimination is possible but requires 
extensive dog vaccinations that can be costly. Canine rabies 
can cause substantial economic loss, but it is completely 
preventable and its prevention is economically efficient. 
Elimination is possible if political will generates enough 
support for successful mass dog vaccination campaigns. 
Conclusions
Not all losses from zoonotic diseases are preventable 
(4, 43). In some cases, effective vaccines do not exist for all 
of the main vectors and, in the case of highly contagious 
zoonoses, large outbreaks can happen rapidly and involve 
thousands of people simultaneously. In addition, for those 
zoonotic diseases that have high morbidity implications, 
illness can persist for a long time, causing economic impacts 
for many years. Rabies, however, is unique, in that the 
economic impact of the disease is not a result of morbidity 
and is only associated with mortality to a limited extent; 
rather, it is mainly the result of management of the disease 
and treatment to prevent human death.  This zoonosis is 
unique in that a vaccine exists for almost all of the reservoir 
species and certainly the most important, namely dogs, and 
this means elimination is feasible. The result of all of these 
factors is that economic gains can be made by the successful 
elimination of the disease.
A consistent finding across most studies of the economic 
impact of rabies is that vaccinating reservoir species is key 
to reducing impacts. In terms of canine rabies, the evidence 
is clear and consistent: vaccination of dogs reduces human 
impacts in terms of human death and causes a decrease in 
the number of PEP treatments carried out. Those countries 
or regions most impacted by rabies are those that choose 
to invest less in dog vaccination efforts and more in PEP. 
This is best exemplified by Asia, which experiences over 
half of all human and cattle deaths while performing 
more than 90% of PEP vaccinations and about half of dog 
vaccine administrations. Asia invests the least in PEP and 
dog vaccination per human death. Latin America invests 
heavily in human death prevention in that, for every human 
death, it has administered over 40,000 PEP treatments and 
vaccinated 2.8 million dogs. Asia, however, only performs 
eight PEP treatments and eight dog vaccinations per human 
death. This conclusively determines why there is minimal 
loss of human life in Latin America due to rabies and 
substantial loss of life to rabies in Asia.  
Enough economic analysis has been conducted globally to 
prove that canine rabies elimination can be economically 
efficient and provide a positive return on investment. 
Future economic analysis will likely be able to illustrate the 
trade-offs between different management goals and budget 
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constraints. Managers will be able to clearly illustrate the 
value of mass dog vaccination campaigns in reducing the 
need for PEP and saving human lives. Ultimately, this 
Análisis de la relación costo-beneficio del control de la rabia, 
o cómo hacer de la economía el eje de la lucha antirrábica para 
aglutinar la voluntad política
S.A. Shwiff, J.L. Elser, K.H. Ernst, S.S. Shwiff & A.M. Anderson
Resumen
La rabia es una zoonosis que reviste importancia económica. Los autores 
exponen la magnitud del impacto económico de la enfermedad y algunas 
de las modalidades de análisis económico utilizadas para aprehender esas 
consecuencias, así como el juego de equilibrios entre las medidas de gestión de 
la rabia y las actividades destinadas a eliminarla. En muchos casos, la eliminación 
de la enfermedad ofrece a la larga mayor eficacia, en relación con el costo, que 
la continua labor de administración de profilaxis tras exposición, realización de 
pruebas en animales y vacunación de estos. Los análisis económicos sirven 
para fundamentar y encauzar las decisiones de planificación y para aglutinar la 
voluntad política, haciendo de los aspectos económicos un eje de la lucha contra 
la rabia.
Palabras clave
Análisis de la relación costo-beneficio – Economía de la salud – Profilaxis tras exposición 
– Rabia – Vacunación canina – Zoonosis.
Analyse du rapport coûts-bénéfices de la lutte contre la rage : 
placer l’économie au cœur de la lutte contre la rage pour mobiliser 
la volonté politique
S.A. Shwiff, J.L. Elser, K.H. Ernst, S.S. Shwiff & A.M. Anderson
Résumé
La rage est une zoonose importante au plan économique. Les auteurs décrivent 
la portée de l’impact économique de la rage et présentent quelques modèles 
d’analyse économique utilisés pour comprendre ces effets ; ils analysent 
également les compromis à trouver entre les efforts consacrés à la gestion de 
la rage et ceux dédiés à son élimination. Dans bien des cas, il est plus rentable 
sur le long terme d’éliminer la rage que de procéder à la gestion continue de 
la prophylaxie post-exposition chez l’homme et au dépistage et à la vaccination 
des animaux. Les analyses économiques servent à documenter et à orienter les 
décisions concernant les mesures à prendre afin de mobiliser la volonté politique 
nécessaire, en plaçant l’économie au cœur de la lutte contre la rage.
Mots-clés
Analyse du rapport coûts-bénéfices – Économie de la santé – Prophylaxie post-exposition 
– Rage – Vaccination des chiens – Zoonose.
should generate the political support needed to meet the 
goal of eliminating canine rabies worldwide by 2030.
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